6-aminohexanoic acid is a lipid of Fatty Acyls (FA) class. 6-aminohexanoic acid is associated with abnormalities such as Blood Clot, Myocardial Infarction, Cerebrovascular accident, Renal impairment and Scoliosis, unspecified. The involved functions are known as Fibrinolysis, Agent, Hemorrhage, plasminogen activation and inhibitors. 6-aminohexanoic acid often locates in Chest, Blood, Body tissue, peritoneal and Plasma membrane. The associated genes with 6-aminohexanoic acid are P4HTM gene, BSND gene, MTPN gene, NDUFS4 gene and Homologous Gene. The related lipids are Phosphatidylserines and Butyric Acid.
To understand associated biological information of 6-aminohexanoic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
6-aminohexanoic acid is suspected in Cerebrovascular accident, Blood Clot, Myocardial Infarction, Renal impairment, Thromboembolism, Postoperative myocardial infarction and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with 6-aminohexanoic acid
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Stricker PA et al. | Population pharmacokinetics of ϵ-aminocaproic acid in adolescents undergoing posterior spinal fusion surgery. | 2015 | Br J Anaesth | pmid:25586726 |
Bitkova EE et al. | [Prophylaxis of blood loss and allogenic blood transfusion with fibrinolysis inhibitors produced in Russian Federation in patients undergoing cardiac surgery]. | 2014 Mar-Apr | Anesteziol Reanimatol | pmid:25055497 |
Scepansky E et al. | Acquired von Willebrand syndrome with a type 2B phenotype: diagnostic and therapeutic dilemmas. | 2014 | Acta Haematol. | pmid:24296552 |
Kong HY et al. | Epsilon-aminocaproic acid improves postrecirculation hemodynamics by reducing intraliver activated protein C consumption in orthotopic liver transplantation. | 2014 | World J Surg | pmid:24142329 |
Verma K et al. | The relative efficacy of antifibrinolytics in adolescent idiopathic scoliosis: a prospective randomized trial. | 2014 | J Bone Joint Surg Am | pmid:24875032 |
Bandari RP et al. | Synthesis and biological evaluation of copper-64 radiolabeled [DUPA-6-Ahx-(NODAGA)-5-Ava-BBN(7-14)NH2], a novel bivalent targeting vector having affinity for two distinct biomarkers (GRPr/PSMA) of prostate cancer. | 2014 | Nucl. Med. Biol. | pmid:24508213 |
Two AM et al. | Reduction in serine protease activity correlates with improved rosacea severity in a small, randomized pilot study of a topical serine protease inhibitor. | 2014 | J. Invest. Dermatol. | pmid:24213369 |
Durkan K et al. | A heterodimeric [RGD-Glu-[(64)Cu-NO2A]-6-Ahx-RM2] αvβ3/GRPr-targeting antagonist radiotracer for PET imaging of prostate tumors. | 2014 | Nucl. Med. Biol. | pmid:24480266 |
Fletcher DJ et al. | Evaluation of tranexamic acid and ε-aminocaproic acid concentrations required to inhibit fibrinolysis in plasma of dogs and humans. | 2014 | Am. J. Vet. Res. | pmid:25061704 |
Sukegawa T | [A case of allergic contact dermatitis due to unit dose type purified sodium hyaluronate ophthalmic solution]. | 2014 | Nippon Ganka Gakkai Zasshi | pmid:24640792 |